11/18/2024
3:49 PM | Inhibikase Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
7:30 AM | Inhibikase Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
3:07 PM | Inhibikase Therapeutics (Filer)
| Form PRE 14A | |
10/28/2024
4:26 PM | Inhibikase Therapeutics (Subject)
SP IKT Holdings LLC (Filed by)
| Form SC 13G | |
10/28/2024
3:00 PM | Inhibikase Therapeutics (Subject)
Soleus Private Equity Fund III, L.P. (Filed by)
| Form SC 13G | |
10/25/2024
4:52 PM | Inhibikase Therapeutics (Issuer)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
Sands Capital Ventures, LLC (Reporting)
SANDS FRANK M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2024
4:50 PM | Inhibikase Therapeutics (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
| Form SC 13G | |
|
10/23/2024
6:58 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:35 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:36 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:38 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:40 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:43 PM | Inhibikase Therapeutics (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:49 PM | Inhibikase Therapeutics (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:53 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:15 PM | Inhibikase Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/21/2024
8:13 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
6:00 PM | Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
| Form SC 13G | |
10/17/2024
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Inhibikase Therapeutics (Subject)
| Form SC 13G | |
10/10/2024
4:31 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:40 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
8:21 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
4:23 PM | Dion Gisele (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:27 PM | GRINT PAUL C (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:18 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:20 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
8:25 PM | Inhibikase Therapeutics (Filer)
| Form 424B3 | |
06/26/2024
11:15 PM | Inhibikase Therapeutics (Filer)
| Form EFFECT | |
06/21/2024
3:30 PM | Inhibikase Therapeutics (Filer)
| Form DEFA14A | |
06/20/2024
5:06 PM | Inhibikase Therapeutics (Filer)
| Form DEF 14A | |
06/18/2024
4:27 PM | Inhibikase Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/10/2024
3:20 PM | Inhibikase Therapeutics (Filer)
| Form PRE 14A | |
05/22/2024
7:55 AM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
05/20/2024
7:55 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
6:09 AM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
05/15/2024
6:56 AM | Inhibikase Therapeutics (Filer)
| Form RW | |
05/09/2024
1:41 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
04/30/2024
7:17 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:20 PM | Inhibikase Therapeutics (Filer)
| Form ARS | |
04/26/2024
3:15 PM | Inhibikase Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
3:29 PM | Inhibikase Therapeutics (Filer)
| Form S-1/A | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
04/19/2024
4:14 PM | Inhibikase Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/18/2024
8:46 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
4:12 PM | Inhibikase Therapeutics (Filer)
| Form 8-K/A | |
04/02/2024
4:12 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
4:14 PM | Inhibikase Therapeutics (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
6:59 AM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
3:49 PM | Inhibikase Therapeutics (Filer)
| Form 424B5 | |
01/16/2024
3:31 PM | Inhibikase Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
